China's Sino Biopharm has announced the completion of a binding Sale and Purchase Agreement to acquire LaNova Medicines....
CorestemChemon, a leading GLP-certified preclinical CRO based in South Korea, has entered into a strategic partners...
Hyphens Pharma, a subsidiary of Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical...
Japan-based Astellas Pharma Inc. has agreed on a Memorandum of Understanding (MoU) with the Korea Institute of Star...
Thermo Fisher Scientific Inc. has announced an expansion of their strategic partnership with Sanofi to enable additional...
365mc, South Korea's leading medical institution specialising in fat reduction treatments, and Israel-based Ra...
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of India-based Biocon Ltd. has ...
In the newly released "Paediatric drug optimisation for respiratory syncytial virus (PADO-RSV) meeting report" by Global...
Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...
A significant advancement in weight management has arrived for Singaporeans. Novo Nordisk, a global healthcare company f...
South Korea-based biopharmaceutical company Samsung Bioepis has published a whitepaper titled ‘Solving the Biosimi...
DKSH Business Unit Healthcare, a Strategic Healthcare Solutions Partner and leading provider of Market Expansion Service...
Japan's JCR Pharmaceuticals Co. has entered into a license agreement with Alexion, AstraZeneca Rare Disease, for JCR&rsq...
China-based CStone Pharmaceuticals has announced an exclusive partnership with Istituto Gentili, a leading European biop...
Health2Sync, Asia's leading digital chronic disease management platform, has announced the successful integration of Sma...
Celltrion has announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimila...
Japan's Chugai Pharmaceutical and Gero, a Singapore-based biotechnology company, have entered into a joint research...
BioVersys AG, a multi-asset, clinical stage biopharmaceutical company based in Switzerland, focusing on research an...
